Hepatitis c and Heavy or prolong menstrual bleeding

Summary:

Heavy or prolong menstrual bleeding is found among people with Hepatitis c, especially for people who are female, 40-49 old.

The study analyzes which people have Heavy or prolong menstrual bleeding with Hepatitis c. It is created by eHealthMe based on reports of 117 people who have Hepatitis c from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hepatitis c?

Hepatitis c is found to be associated with 787 drugs and 984 conditions by eHealthMe. Check the latest studies of Hepatitis c.

What is Heavy or prolong menstrual bleeding?

Heavy or prolong menstrual bleeding is found to be associated with 749 drugs and 1,264 conditions by eHealthMe. Check the latest studies of Heavy or prolong menstrual bleeding.

On Jul, 14, 2026

117 people who have Hepatitis C and Heavy Or Prolong Menstrual Bleeding are studied.

Would you have Heavy or prolong menstrual bleeding when you have Hepatitis c?

Gender of people who have Hepatitis c and experienced Heavy or prolong menstrual bleeding *:

Click here to view

Age of people who have Hepatitis c and experienced Heavy or prolong menstrual bleeding *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Heavy or prolong menstrual bleeding?

- Check whether Heavy or prolong menstrual bleeding is associated with a drug or a condition

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .

Related studies:

Treatments, associated drugs and conditions:

Hepatitis c (131,813 reports)
Heavy or prolong menstrual bleeding (38,063 reports)

All the drugs that are associated with Heavy or prolong menstrual bleeding:

Heavy or prolong menstrual bleeding (749 drugs)

All the conditions that are associated with Heavy or prolong menstrual bleeding:

Heavy or prolong menstrual bleeding (1,264 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Heavy or prolong menstrual bleeding and Hepatitis c, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.